A spate of recent studies have used diverse in vivo models to demonstrate a functional role for NKG7 in CD4+ T cells (visceral leishmaniasis), CD8+ T cells (malaria), NK cells (melanoma) (25) and in CD8+ T cell driven anti-tumor immunity (20, 21). This evidence concerns the gene CD4 and melanoma.